Annual report pursuant to Section 13 and 15(d)

Fair Value Measurement and Derivatives (Tables)

v3.7.0.1
Fair Value Measurement and Derivatives (Tables)
12 Months Ended
Dec. 31, 2016
Fair Value Disclosures [Abstract]  
Schedule of Liabilities Measured at Fair Value

The following two tables set forth the Company’s consolidated financial assets and liabilities measured at fair value by level within the fair value hierarchy at December 31, 2016 and 2015. Assets and liabilities are classified in their entirety based on the lowest level of input that is significant to the fair value measurement.

 

    Fair value at                    
    December 31, 2016     Level 1     Level 2     Level 3  
Preferred stock embedded conversion feature   $ 123,266     $ -     $ -     $ 123,266  
Anti-dilution provision in common stock warrants included with preferred stock     52,904       -       -       52,904  
Debenture embedded conversion feature     25,884       -       -       25,884  
Anti-dilution provision in common stock warrants included with debentures     10,988       -       -       10,988  
Total derivatives   $ 213,042     $ -     $ -     $ 213,042  

 

    Fair value at                    
    December 31, 2015     Level 1     Level 2     Level 3  
Preferred stock embedded conversion feature   $ 376,065     $ -     $ -     $ 376,065  
Anti-dilution provision in common stock warrants included with preferred stock     51,203       -       -       51,203  
Debenture embedded conversion feature     560,778       -       -       560,778  
Anti-dilution provision in common stock warrants included with debentures     79,943       -       -       79,943  
Total derivatives   $ 1,067,989     $ -     $ -     $ 1,067,989  

Schedule of Reconciliation of Level 3 Conversion Option Liability

The following tables present a reconciliation of the beginning and ending balances of items measured at fair value on a recurring basis that use significant unobservable inputs (Level 3) and the related realized and unrealized (gains) losses recorded in the consolidated statements of operations during the period:

 

  Year Ended December 31, 2016
    Preferred stock embedded conversion feature     Anti-dilution provision in common stock warrants included with preferred stock     Debenture embedded conversion feature     Anti-dilution provision in common stock warrants included with debentures     Total  
                               
Fair value, December 31, 2015   $ 376,065     $ 51,203     $ 560,778     $ 79,943     $ 1,067,989  
                                         
Net unrealized gain on derivatives     (277,337 )     (52,800 )     (408,919 )     (68,955 )     (808,011 )
                                         
Purchases and issuances (sales and settlements)     24,538       54,501       (125,975 )           (46,936 )
                                         
Fair value, December 31, 2016   $ 123,266     $ 52,904     $ 25,884     $ 10,988     $ 213,042  
                                         
Changes in unrealized gains, included in income on instruments held at end of year   $ (277,337 )   $ (52,800 )   $ (408,919 )   $ (68,955 )   $ (808,011 )

 

    Year Ended December 31, 2015  
    Preferred stock embedded conversion feature     Anti-dilution provision in common stock warrants included with preferred stock     Debenture embedded conversion feature     Anti-dilution provision in common stock warrants included with debentures     Total  
                                         
Fair value, December 31, 2014   $     $     $             $  
                                         
Net unrealized (gains)/loss on derivatives     205,509       23,503       (85,319 )     (12,163 )     131,530  
                                         
Purchases and issuances (sales and settlements)     170,556       27,700       646,097       92,106       936,459  
                                         
Fair value, December 31, 2015   $ 376,065     $ 51,203     $ 560,778     $ 79,943     $ 1,067,989  
                                         
Changes in unrealized (gains)/losses, included in income on instruments held at end of year   $ 205,509     $ 23,503     $ (85,319 )   $ (12,163 )   $ 131,530